data requirements for biosimilars
Published 6 years ago • 26K plays • Length 5:20Download video MP4
Download video MP3
Similar videos
-
1:58
fda review and approval process for biosimilar medications
-
2:47
biosimilars: approval process
-
16:06
data quality expectations for biosimilars with case studies (29of33) quality – oct. 16-17, 2019
-
42:43
regulatory highlights for biosimilars and interchangeables (9of15) redi – may 29-30, 2019
-
4:12
the basics of biosimilars
-
22:48
navigating the world of biosimilar user fees- june 10, 2019
-
3:02
biosimilar medications — what patients need to know
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
4:20
the biosimilar development process
-
14:19
regulatory pathway for biosimilars
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
2:03
biosimilars interchangeability
-
3:12
biosimilars: critical quality attributes
-
1:36
interchangeable biosimilars
-
3:07
the promise of biosimilars
-
36:55
components of new drug application and biologics license application (5of15) redi– may 29-30, 2019
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
2:55:17
increasing the efficiency of biosimilar development programs (day 1)